相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between EPHX1 polymorphisms and carbamazepine metabolism in epilepsy: a meta-analysis
Gui-Xin Zhao et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2019)
Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients
Chahra Chbili et al.
JOURNAL OF NEUROGENETICS (2016)
Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy
Chun-Lai Ma et al.
PHARMACOGENOMICS (2015)
Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients
Armond Daci et al.
PLOS ONE (2015)
Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy
Xu Zhu et al.
PHARMACOGENOMICS (2014)
Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy
Wenting Yun et al.
EPILEPSY RESEARCH (2013)
Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy
Yogita Ghodke Puranik et al.
PHARMACOGENOMICS (2013)
Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization
Chin-Chuan Hung et al.
PHARMACOGENOMICS (2012)
PharmGKB summary: carbamazepine pathway
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Genetic Variants in Microsomal Epoxide Hydrolase Influence Carbamazepine Dosing
Mohd Makmor-Bakry et al.
CLINICAL NEUROPHARMACOLOGY (2009)
Association between SCN1A polymorphism and carbamazepine-resistant epilepsy
Tomohide Abe et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Several major antiepileptic drugs are substrates for human P-glycoprotein
Carlos Luna-Tortos et al.
NEUROPHARMACOLOGY (2008)
A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dose
Sarah K. Tate et al.
PHARMACOGENETICS AND GENOMICS (2006)
Comparison of two methods to detect publication bias in meta-analysis
JL Peters et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
HEGESMA: genome search meta-analysis and heterogeneity testing
E Zintzaras et al.
BIOINFORMATICS (2005)
Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin
SK Tate et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients
Y Nakajima et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Cost-effectiveness of therapeutic drug monitoring - A systematic review
DJ Touw et al.
THERAPEUTIC DRUG MONITORING (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Non-synonymous single nucleotide alterations in the microsomal epoxide hydrolase gene and their functional effects
K Maekawa et al.
XENOBIOTICA (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
分享论文
